reports
- Ewa Manthey
- Warren Patterson
Kyocera Corporation to Exhibit at Automotive Engineering Exposition 20...
KYOTO, Japan--(BUSINESS WIRE)-- Kyocera Corporation (President: Hideo Tanimoto) announced its participation in the Automotive Engineering Exposition 2024 in Pacifico Yokohama, Kanagawa Prefecture May 22-24 (booth #N32). Kyocera will showcase a compact FIR auto sensor that detects pedestrians and vehicles even in darkness or severe weather conditions, and an experiential demo of an electronic motorcycle throttle with precise sensor control to enable safer driving. Additionally, Kyocera will introduce in-car related components, products, and technologies. Recognized as one of Japan's premier sho...
- Benjaphol Suthwanish
- Chong Lee Len
- Damon Shen
- Jieqi Liu
- Limartha Adhiputra
- Llelleythan Tan Tan
- Tanaporn Visaruthaphong
- Tham Mun Hon
- Wei Xiang Ku
Regional Morning Meeting Notes: Monday, May 20, 2024
GREATER CHINA Economics Economic Activity April data reflects uneven progress. Sector Property The central government announced a solid policy combo to revive buyers’ sentiment, marking a positive action to mitigate the property industry’s risks. INDONESIA Results Indo Tambangraya Megah (ITMG IJ/SELL/Rp24,075/Target: Rp21,500) 1...
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering ...
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study ATLANTA, May 19, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company” or “Virios Therapeutics”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases, including fibromyalgia (“FM”) and Long-COVID (“LC”), today announced the pricing of its previously announced public offering of 8,500,000 shares of its common stock at a public offering ...
- Limartha Adhiputra
Indo Tambangraya Megah (ITMG IJ) - 1Q24: NPAT Drops 34.8% qoq On Lower...
ITMG delivered a 1Q24 NPAT of US$61.6m, declining 66.3% yoy and 34.8% qoq mainly due to softer yoy ASP and lower qoq coal sales volume. The results were below expectations, but could improve in the next quarter as the sales volume might return to normal. We estimate 2024 and 2025 NPAT at US$346m (-30.7% yoy) and US$248m (- 28.3% yoy) respectively. Maintain SELL with a lower target price of Rp21,500.
- Chong Lee Len
- Llelleythan Tan Tan
Singapore Daily - Monday, May 20, 2024
KEY HIGHLIGHTS Results NetLink NBN Trust (NETLINK SP/BUY/S$0.865/Target: S$0.98): FY24: Soft results from higher costs; overall connections continue to grow. TRADERS’ CORNER Yangzijiang Financial Holding (YZJFH SP): Trading BUY Oversea-Chinese Banking Corp (OCBC SP): Trading BUY
- Limartha Adhiputra
- Maskun Ramli
- Lynn Song
- Rob Carnell
- Simen Mortensen
Equity raise, two more Q1 reports
This week, Nyfosa raised SEK1.7bn in equity, and Citycon and Olav Thon reported their Q1 results. Real estate stocks have performed well globally since the latest US CPI print. The weighted-average implied EBITDA yields on the stocks we cover are 4.32% for 2024e and 4.71% for 2025e.
OLT OLAV THON EIENDOMSSELSKAP ASA
BALD B FASTIGHETS AB BALDER CLASS B
CAST CASTELLUM AB
CATE CATENA AB
WALL B WALLENSTAM AB CLASS B
ATRLJ B ATRIUM LJUNGBERG AB CLASS B
KMCP KMC PROPERTIES
ENTRA ENTRA ASA
POX PANDOX AB CLASS B
SBB B SAMHALLSBYGGNADSBOLAGET I NORDEN AB CLASS B
FABG FABEGE AB
WIHL WIHLBORGS FASTIGHETER AB
CORE B COREM PROPERTY GROUP (B)
KOJAMO KOJAMO OYJ
CTY1S CITYCON OYJ
NYF NYFOSA AB
SAGAB SAGAX
AURA AURORA EIENDOM
Qifu Technology Announces First Quarter 2024 Unaudited Financial Resul...
Qifu Technology Announces First Quarter 2024 Unaudited Financial Results SHANGHAI, China, May 19, 2024 (GLOBE NEWSWIRE) -- Qifu Technology, Inc. (NASDAQ: QFIN; HKEx: 3660) (“Qifu Technology” or the “Company”), a leading Credit-Tech platform in China, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Business Highlights As of March 31, 2024, our platform has connected 159 financial institutional partners and 241.4 million consumers*1 with potential credit needs, cumulatively, an increase of 12.5% from 214.5 million a year ago.C...
- ABGSC Strategy Research
- Amanda Alla
- Christer Linde
- ABGSC IT Research
- Daniel Thorsson
- Nikola Kalanoski
- Miika Ihamaki
- Linus Sigurdson
Key Energy Services Reports Asset Acquisition
Key Energy Services Reports Asset Acquisition HOUSTON, May 19, 2024 (GLOBE NEWSWIRE) -- Key Energy Services, Inc. (“Key” or the “Company”) today announced the purchase of substantially all the assets of the well servicing division of Endeavor Energy Resources, L.P. (“Endeavor”) in an all-cash transaction effective May 19, 2024. Key will continue support Endeavor’s well servicing needs in the Permian Basin with these assets. Key’s President and Chief Executive Officer, Marshall Dodson, stated, “We are excited about this transaction and the great people and assets we have added to our team...
Savara Presented New Data on Autoimmune Pulmonary Alveolar Proteinosis...
LANGHORNE, Pa.--(BUSINESS WIRE)-- (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego, CA. Savara’s partner, Trillium Health LLC, presented a poster on the laboratory blood test that was recently developed to aid in the diagnosis of aPAP. Below are summaries of the posters presented: Poster Board 701: “Healthcare Burden of Pulmonary Alveolar Proteinosis” presented by E. Lee, M.D., Ph.D.; sponso...
Dyne Therapeutics to Host Virtual Investor Event to Review New Clinica...
Dyne Therapeutics to Host Virtual Investor Event to Review New Clinical Data from the ACHIEVE and DELIVER Trials Tomorrow, May 20 at 8:00 a.m. ET WALTHAM, Mass., May 19, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced it now plans to report new efficacy and safety data from its Phase 1/2 ACHIEVE and DELIVER clinical trials on May 20, 2024, and to host a virtual event at 8:00 a.m. ET. This represents an update to Dyne’s prior ...
- Jonathan Moreland
RIGN TRANSOCEAN LTD.
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
AFB ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
NWPP NEW PEOPLES BANKSHARES INC.
FSK FS KKR CAPITAL CORP
RRBI RED RIVER BANCSHARES
HQL TEKLA LIFE SCIENCES INVESTORS
HQI HIREQUEST INC.
TLS TELOS
VPV INVESCO PA VALUE MUNI INC TST
MEGI MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
MIO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
Silvano Fashion Group Consolidated Interim Financial Report for Q1 of ...
Silvano Fashion Group Consolidated Interim Financial Report for Q1 of 2024 (unaudited) Silvano Fashion Group Consolidated Interim Financial Report for Q1 of 2024 (unaudited) Selected Financial Indicators Summarized selected financial indicators of the Group for Q1 of 2024 compared to Q1 of 2023 and 31.03.2024 compared to 31.12.2023 were as follows: in thousands of EUR Q1 2024 Q1 2023 Change Revenue 13 904 14 141 -1.7% Gross Profit 7 789 8 124 -4.1% Operating profit 3 548 3 963 -10.5% EBITDA 4 298 4 761 -9.7% Net profit for the period 2 916 1 867 56.2% Ne...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.